EAS 2008: Treating dyslipidemia "beyond statins" -- the latest reports from the 2008 EAS conference concern ADAGIO-Lipids, apoC-III, and a new class of drugs for increasing HDL cholesterol. Medscape Cardiology
The FDA has approved revisions to the safety labeling for a fluocinolone acetonide intravitreal implant, levothyroxine sodium tablets, and amlodipine plus valsartan tablets. Medscape Medical News
The benefits of eating a dark chocolate bar, a cocoa-flavanols-rich product supplemented with plant sterols, occurred without any weight gain, suggesting it might be helpful in the dietary management of cardiovascular risk, say investigators. Heartwire
A study shows that impaired chronotropic response after exercise treadmill testing is an effective, noninvasive tool to evaluate cardiac risk in patients with diabetes. Medscape Medical News
After controlling for baseline differences, survival rates after percutaneous coronary intervention are higher in both men and women, although women have made greater gains. Medscape Medical News